Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections

[1]  K. Tateda,et al.  [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010]. , 2012, The Japanese journal of antibiotics.

[2]  Ş. Çolakoğlu,et al.  Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  M. Karabel,et al.  Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006 , 2009, International Urology and Nephrology.

[4]  T. Mackenzie,et al.  Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. , 2008, The American journal of medicine.

[5]  R. Raz,et al.  Risk Factors for Community-Acquired Urinary Tract Infection Due to Quinolone-Resistant E. coli , 2008, Infection.

[6]  F. Dunstan,et al.  Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. , 2007, The Journal of antimicrobial chemotherapy.

[7]  R. Negrini,et al.  Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[8]  Tetsurou Matsumoto,et al.  Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae. , 2006, International journal of antimicrobial agents.

[9]  Jae-Hyuk Jang,et al.  New Dihydrobenzofuran Derivative, Awajanoran, from Marine-derived Acremonium sp. AWA16-1 , 2006, The Journal of Antibiotics.

[10]  J. Vila,et al.  Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. , 2006, The Journal of antimicrobial chemotherapy.

[11]  O. Ergönül,et al.  Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. , 2005, The Journal of antimicrobial chemotherapy.

[12]  K. Angamuthu,et al.  Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. , 2005, Saudi medical journal.

[13]  Tetsurou Matsumoto,et al.  Bacterial resistance to antimicrobials in urinary isolates. , 2004, International journal of antimicrobial agents.

[14]  A. Nagayama,et al.  [Antibacterial activity of oral Cephems against various clinically isolated strains]. , 2003, The Japanese journal of antibiotics.

[15]  Tetsurou Matsumoto,et al.  [Urinary tract infection]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[16]  Ronald N. Jones,et al.  Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). , 2002, Diagnostic microbiology and infectious disease.

[17]  W. Mckerrow,et al.  Urinary tract infection in children. , 1984, British medical journal.